Send feedback

CRB2 p.Asp322=

c.966C>T · rs753016438 · VCV1576581

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.018%, mid)
Conditions
2
focal segmental glomerulosclerosis 9

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -4.8GERP -3.8
Overall
CADD8.161PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.018% Middle Eastern · 1/5,564 alleles
Filtering AF 0.00627% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00429%
Overall 0.00429% 67/1,562,206 alleles · ultra-rare exomes 61/1,410,076 · genomes 6/152,130 · joint denominator
Ancestry group Frequency 1 in
Middle Easterngrpmax 0.018% 5,564
East Asian 0.0144% 6,927
African / African-American 0.00544% 18,370
European (non-Finnish) 0.00451% 22,197
Remaining individualsnot grpmax-eligible 0.00331% 30,252
Finnishnot grpmax-eligible 0.00169% 59,162
South Asian 0.00118% 84,698

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CRB2
Protein
p.Asp322=
Coding
c.966C>T
MANE Select
NM_173689
dbSNP
rs753016438
Type
single nucleotide variant
Location
chr9:123367598 (GRCh38)
Gene constraint
LOEUF 1.202 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 76.95 · 1 PDB
Residue 322
the 'required for maximum inhibition of app amyloid-beta peptide secretion' region; the egf-like 7; calcium-binding domain; a UniProt-annotated variant site (in fsgs9; uncertain significance)
Full CRB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/crb2-p-asp322 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown